Key result
Noncontrast 3DE shows ~40% lower temporal variability for sequential LVEF measurement versus 2D methods.
Why the study?
Decisions regarding cancer therapy rely on temporal changes in EF, but the echocardiographic method with the lowest temporal variability was unknown.
Does noncontrast 3-dimensional echocardiography improve the reproducibility of sequential left ventricular ejection fraction and volume measurements compared to 2D methods in breast cancer patients undergoing chemotherapy?
Population
56 female breast cancer chemotherapy patients with stable LV function
Comparison
2D-biplane Simpson's method vs 2D-triplane vs 3DE with and without contrast
Design
Blinded prospective observational study
Follow-up
1 year
Authors
Loading...
May improve reliability of serial LVEF monitoring during chemotherapy; leaves open effects on outcomes pending randomized validation.
Observational (n=56)
Blinded to clinical data
Does noncontrast 3-dimensional echocardiography improve the reproducibility of sequential left ventricular ejection fraction and volume measurements compared to 2D methods in breast cancer patients undergoing chemotherapy?
Absolute Event Rate: 0.06% vs 0.1%
Noncontrast 3D echocardiography is the most reproducible technique for sequential assessment of LVEF and volumes in patients undergoing chemotherapy, outperforming 2D methods.
Thavendiranathan et al. (2012) conducted an observational in Breast cancer undergoing chemotherapy (n=56). Noncontrast 3-dimensional echocardiography (3DE) vs. 2D-biplane Simpson's method, 2D-triplane, and contrast-enhanced methods was evaluated on Temporal variability of left ventricular ejection fraction and volumes. Noncontrast 3-dimensional echocardiography had the lowest temporal variability for sequential LVEF measurement (0.06 vs >0.10 for 2D methods) over 1 year of follow-up.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: